Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

AdventHealth200 enrolled

Overview

To evaluate a community-based outreach initiative for screening, diagnosis, and treatment of breast, lung, and prostate cancers in underserved adults using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) implementation science framework.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Breast Cancer Lung Cancer (Diagnosis)Prostate Cancer

Interventions

referral for definitive diagnosis based on their cancer screening resultsBEHAVIORAL

Need for radiological diagnosis

EngagementBEHAVIORAL

Engage in stakeholder focus groups to provide feedback about program operations

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Adult aged 18 or older 2. Seeking care at a CRS or emergency department 3. Meets criteria for lung, breast, and/or prostate cancer screening, as outlined below: 1. Lung cancer: Adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years 2. Breast cancer: Women aged 40 to 74 years 3. Prostate cancer: Men aged 55 to 69 years 4. Receives a positive screening result for lung, breast, and/or prostate cancer at a study site Exclusion Criteria: 1. Displays behavior disruptive to other patients or staff 2. Refusal to accept screening for breast, lung, and/or prostate cancers

Locations (1)

Adventhealth

Orlando, Florida, United States

RECRUITING

Outcomes

Primary Outcomes

The categorization of the RE-AIM model dimensions of Reach, Effectiveness, Adoption, Implementation, and Maintenance,

Reach will assess the percentage and characteristics of patients screened or excluded, as well as participant versus non-participant profiles. Effectiveness will measure the proportion of positive screens referred for confirmatory diagnostics and compare screening rates to Healthy People 2030 goals. Adoption will track provider education on breast, lung, and prostate cancer screening guidelines, uptake of screening practices, and staff engagement with navigation programs. Implementation will evaluate referrals to navigation, screening rates, and for positive screens: referral time, diagnostic barriers, treatment uptake, and clinical trial screening. Maintenance will examine primary outcomes at three months, progress toward HP2030 goals, attrition rates, and differences by patient characteristics.

Time frame: From enrollment to the end of the 3 month follow-up for a total of 12 months

Secondary Outcomes

PROMIS Global Health (HR-QoL) scale

A 10-item scale to assess physical, mental, and social health on a scale of 5 (Excellent) to 1 (Poor), ability to carry out everyday activities on a scale of 5 (Completely) to 1 (Not at all), emotional problems on a scale of 5 (Never) to 1 (Always), fatigue on a scale of 5 (None) to 1 (Very severe), and pain on a scale of 0 (No pain) to 10 (Worst imaginable pain)

Time frame: From enrollment to the end of the 3 month follow-up for a total of 12 months

Patient Satisfaction with Logistical Aspects of Navigation Scale (PSN-L)

A 26-item scale to assess satisfaction with the navigation program on a scale of 3 (Very satisfied) to 1 (Not Satisfied)

Time frame: From enrollment to the end of the 3 month follow-up for a total of 12 months

Central Contacts

Patricia Robinson, PhD

CONTACT

407-303-3286 patricia.robinson@adventhealth.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.